ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) headquartered in Baudette, will host a conference call for the investment community to discuss the 3Q20 earnings result on 5th November 2020 at 10:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.anipharmaceuticals.com
Earnings Expectation
ANI Pharmaceuticals, Inc. specialty pharma firm, is expected to report third quarter earnings results, before market open, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.88 per share from revenue of $ 51.50 million. Looking ahead, the full year income are expected at $ 3.59 per share on the revenues of $ 204.37 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 213.00 million ~ $ 223.00 million, where as bottomline are predicted in a range of $ 4.46 ~ $ 4.86 per share
Click Here For More Historical Outlooks Of ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncolytics (anti-cancers), hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract manufacturing for other pharmaceutical companies.
